ABSTRACT

Competitiveness is the issue. It's producing more of what the market demands faster and at less cost than the competition. Competitiveness is about quality and responsiveness. It's also about meeting government regulations as well as the business issues of ever-higher rates of return on funds invested. In the pharmaceutical business, competitiveness goes hand in hand with earning a reputation for leadership and integrity. Until recently, many of these issues seemed to reside outside the bulk manufacturing arena. No longer!